Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Amgen
Company Monitoring Page for Amgen
latest headlines for company on cafepharma
Years after the first US biosim launches, doctors still have their concerns: survey
Fierce Pharma
Thu, 02/16/23 - 04:49 pm
Tags:
biosimilars
,
PBMs
,
physicians
,
AbbVie
,
Humira
,
Amgen
,
Amjevita
Amgen bond offering to help fund Horizon Therapeutics acquisition
Seeking Alpha
Thu, 02/16/23 - 11:25 am
Tags:
Amgen
,
bond
,
M&A
,
Horizon Therapeutics
BioSpace Layoff Tracker 2023: Grifols, Frequency, Eliem and More Cut Staff
BioSpace
Thu, 02/16/23 - 11:18 am
Tags:
layoffs
,
Grifols
,
Frequency Therapeutics
,
Eliem Therapeutics
,
Aligos Therapeutics
,
Thermo Fisher Scientific
,
Magenta Therapeutics
,
Eisai
,
Amgen
,
Y-mAbs Therapeutics
,
Century Therapeutics
,
Elevation Oncology
,
Calithera Biosciences
,
Editas Medicine
,
Verily
,
Abzena
Layoffs continue to batter biotech, with Big Pharmas piling on the pain
Fierce Biotech
Wed, 02/1/23 - 10:32 pm
Tags:
layoffs
,
Amgen
,
Merck KGaA
,
TCR2 Therapeutics
,
Moderna Therapeutics
Amgen Adopts A Two-Price Strategy For The U.S.’s First Marketed Humira-Referenced Biosimilar, Amjevita
Forbes
Wed, 02/1/23 - 10:41 am
Tags:
Amgen
,
Amjevita
,
AbbVie
,
Humira
,
biosimilars
,
drug pricing
Amgen launches Humira biosimilar, releases Q4 earnings report
Medical Marketing and Media
Tue, 01/31/23 - 11:21 pm
Tags:
Amgen
,
Humira
,
biosimilars
,
earnings
,
AbbVie
,
Amjevita
Humira biosimilars arrive in the US, as Amgen launches first copycat to AbbVie’s blockbuster drug
BioPharma Dive
Tue, 01/31/23 - 12:37 pm
Tags:
AbbVie
,
Humira
,
biosimilars
,
Amgen
Amgen commits $8m to improve clinical trial diversity
Outsourcing Pharma
Tue, 01/31/23 - 10:24 am
Tags:
Amgen
,
clinical trials
,
clinical trial diversity
,
Bristol Myers Squibb
,
Winn Award
Amgen, navigating 'industry headwinds,' puts 300 commercial jobs on chopping block
Fierce Pharma
Mon, 01/30/23 - 10:54 am
Tags:
Amgen
,
layoffs
Warren keeps pressure on pharma, this time targeting Amgen and Indivior buyouts
Fierce Pharma
Mon, 01/30/23 - 10:41 am
Tags:
Elizabeth Warren
,
Senate
,
FTC
,
M&A
,
Amgen
,
Horizon Therapeutics
,
Indivior
,
Opiant Pharmaceuticals
Amgen extends autoimmune pact with small Michigan biotech
Endpoints
Wed, 01/18/23 - 11:02 pm
Tags:
Amgen
,
autoimmune disease
,
Evoq Therapeutics
Amgen prepped to take first slice of AbbVie’s US Humira pie
BioProcess International
Wed, 01/18/23 - 11:00 pm
Tags:
Amgen
,
Humira
,
biosimilars
,
adalimumab
,
Amjevita
NewAmsterdam's Amgen castoff cuts LDL cholesterol in phase 2, opening new front in race to market
Fierce Biotech
Tue, 01/17/23 - 10:32 am
Tags:
NewAmsterdam Pharma
,
Amgen
,
CETP inhibitors
,
obicetrapib
,
clinical trials
Big caps bounce back for biopharma
EP Vantage
Mon, 01/16/23 - 11:14 am
Tags:
pharma stocks
,
Amgen
,
BeiGene
,
Bristol Myers Squibb
,
Gilead Sciences
,
Lantheus Holdings
,
Madrigal Pharmaceuticals
,
Merck
,
Moderna Therapeutics
,
Novo Nordisk
,
Prometheus Biosciences
,
Roche
Biopharma’s bolt-on bonanza is set to continue
EP Vantage
Thu, 01/12/23 - 10:18 am
Tags:
M&A
,
Amgen
,
AstraZeneca
,
Bristol Myers Squibb
,
GSK
,
Ipsen
,
Merck
,
Pfizer
Amgen Boasts Lucrative Acquisitions, Drug Updates, Burgeoning Biosimilars at JPM
BioSpace
Tue, 01/10/23 - 06:43 pm
Tags:
Amgen
,
JPMHC 2023
,
M&A
,
biosimilars
Amgen piles $2B more into pharma's ADC rush in Synaffix pact
Fierce Biotech
Thu, 01/5/23 - 04:42 pm
Tags:
Amgen
,
antibody-drug conjugate
,
Synaffix
Amgen files brief to Supreme Court ahead of oral arguments — with industry amicus support
Endpoints
Tue, 01/3/23 - 10:24 pm
Tags:
Amgen
,
Sanofi
,
Regeneron
,
Supreme Court
,
legal
,
innovation
,
patents
,
Repatha
,
Praluent
ADC deals: Mersana engages with Merck, LegoChem and Amgen collaborate
Biopharma Reporter
Mon, 01/2/23 - 06:41 pm
Tags:
antibody-drug conjugate
,
Merck
,
LegoChem Biosciences
,
Mersana
,
Amgen
,
GSK
,
Janssen
Billionaire John Paulson Stands To Make $500 Million From Horizon’s Sale To Amgen
Forbes
Wed, 12/14/22 - 07:22 pm
Tags:
Amgen
,
M&A
,
Horizon Therapeutics
,
John Paulson
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
a dog would most likely chase a: cat, rock, house
*
Fill in the blank.